temozolomide has been researched along with Thymus Neoplasms in 3 studies
Thymus Neoplasms: Tumors or cancer of the THYMUS GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors retrospectively evaluated 3 patients with progressive, metastatic neuroendocrine tumors of the thymus who were treated with a combination of capecitabine and temozolomide." | 7.79 | Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series. ( Centeno, B; Kvols, L; Morse, B; Saranga-Perry, V; Strosberg, J, 2013) |
| "The authors retrospectively evaluated 3 patients with progressive, metastatic neuroendocrine tumors of the thymus who were treated with a combination of capecitabine and temozolomide." | 3.79 | Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series. ( Centeno, B; Kvols, L; Morse, B; Saranga-Perry, V; Strosberg, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crona, J | 1 |
| Björklund, P | 1 |
| Welin, S | 1 |
| Kozlovacki, G | 1 |
| Oberg, K | 1 |
| Granberg, D | 1 |
| Saranga-Perry, V | 1 |
| Morse, B | 1 |
| Centeno, B | 1 |
| Kvols, L | 1 |
| Strosberg, J | 1 |
| Tsang, LL | 1 |
| Farmer, PB | 1 |
| Gescher, A | 1 |
| Slack, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Gamma Knife Radiosurgery and Temozolomide (Temodar) for Newly Diagnosed Brain Metastases[NCT00582075] | Phase 2 | 25 participants (Actual) | Interventional | 2002-07-31 | Completed | ||
| A Pilot Study Investigating Neoadjuvant Temozolomide-based Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas[NCT00881595] | Phase 2 | 0 participants (Actual) | Interventional | 2009-02-28 | Withdrawn (stopped due to No patients accrued since study opened) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00582075)
Timeframe: 2 years
| Intervention | weeks (Median) |
|---|---|
| Radiosurgery 15-24 Gy + Adjuvant Temozolomide | 31 |
Patients developing distant brain failure (DBF) at one year. An approximation method was used to arrive at the reported percentage. (NCT00582075)
Timeframe: 1 years
| Intervention | percentage of participants (Number) |
|---|---|
| Radiosurgery 15-24 Gy + Adjuvant Temozolomide | 37 |
1 trial available for temozolomide and Thymus Neoplasms
| Article | Year |
|---|---|
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dacarbazine; Drug Evaluation; | 1990 |
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dacarbazine; Drug Evaluation; | 1990 |
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dacarbazine; Drug Evaluation; | 1990 |
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dacarbazine; Drug Evaluation; | 1990 |
2 other studies available for temozolomide and Thymus Neoplasms
| Article | Year |
|---|---|
Treatment, prognostic markers and survival in thymic neuroendocrine tumours. a study from a single tertiary referral centre.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Neuroendo | 2013 |
Treatment of metastatic neuroendocrine tumors of the thymus with capecitabine and temozolomide: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Flu | 2013 |